1 Department of Pediatrics, Tohoku University School of Medicine, Sendai 980, Japan
Patients with hyperphenylalaninemia caused by dihydropteridine reductase (DHPR) deficiency, who show progressive cerebral degeneration despite adequate dietary treatment, may respond to neurotransmitter therapy if the diagnosis is made early.1 The diagnosis of this disorder is therefore urgent. A number of methods that had been shown to be of value in the diagnosis of the disease were discussed previously.2-4 A newer screening method for DHPR mutants that was based on measurement of the reduction state of biopterin in urine by high performance liquid chromatography was described by Milstien et al.5 Furthermore, recently leukocyte enzyme assays6,7 have been used in the diagnosis of DHPR deficiency.
This article has been cited by other articles:
![]() |
A. Maller, K. Hyland, S. Milstien, I. Biaggioni, and I. J. Butler Aromatic L-Amino Acid Decarboxylase Deficiency: Clinical Features, Diagnosis, and Treatment of a Second Family J Child Neurol, September 1, 1997; 12(6): 349 - 354. [Abstract] [PDF] |
||||